Introduction
This article serves as a formal erratum for the study originally published in Theranostics in 2021. The original research identified a critical therapeutic pathway—the miR-125b-5p/p53 axis—through which exosomes derived from mesenchymal stem cells (MSCs) facilitate renal tubular repair following ischemic acute kidney injury (AKI). This correction addresses a figure assembly error in the original publication to ensure the visual data accurately reflects the experimental findings.
The Role of MSC-Exosomes in Kidney Repair
Ischemic AKI remains a significant clinical challenge characterized by high mortality and limited therapeutic interventions. While MSC transplantation shows promise, "cell-free" therapies using MSC-secreted exosomes offer a safer, more standardized alternative. These exosomes carry specific molecular "cargo," including microRNAs (miRNAs), that can modulate cell death pathways in damaged tissues.
The study specifically focused on miR-125b-5p. In the context of AKI, the p53 pathway—often termed the "guardian of the genome"—can become overactivated, leading to excessive apoptosis (programmed cell death) and hindering the regenerative capacity of renal tubules. The researchers demonstrated that miR-125b-5p delivered via MSC-exosomes suppresses p53, shifting the cellular balance from death toward repair and regeneration.
Corrected Visual Evidence: Figure 6E
The primary purpose of this erratum is to provide the corrected version of Figure 6E. This figure utilizes Fluorescence In Situ Hybridization (FISH) and immunofluorescence to track the localization and expression of miR-125b-5p (red) alongside DAPI nuclear staining (blue) within kidney tissue.
As shown in the corrected Figure 6E:
- Sham Group: Displays baseline levels of miR-125b-5p expression.
- I/R Group: Shows the expression profile of the microRNA following ischemia/reperfusion injury without intervention.
- I/R + MSC-exos 100 Group: Demonstrates a marked increase in the miR-125b-5p signal (red) compared to the untreated I/R group. This confirms that the administration of MSC-exosomes successfully delivers the protective microRNA to the injured tubular regions.
Conclusion
The authors clarify that this correction is administrative, addressing an error in figure assembly. The quantitative data, statistical analyses, and the fundamental scientific conclusion—that MSC-exosomes promote tubular repair via the miR-125b-5p/p53 axis—remain entirely unchanged and valid. This erratum ensures the integrity of the published imaging data while reaffirming the study's therapeutic insights into treating ischemic AKI.
Summary updated